NK cells in cerebral ischemia.

Area of Science:

• Neuroimmunology
• Immunology
• Neurology

Background:

• Natural killer (NK) cells are immune cells found in the ischemic brain, bridging immune and nervous system communication during stroke.
• NK cells are implicated in post-stroke inflammation, immune suppression, and infections, which can worsen brain injury and recovery.
• Tissue plasminogen activator (tPA), a common stroke treatment, can exacerbate inflammation, further complicating stroke management.

Purpose of the Study:

• To explore the multifaceted role of NK cells in ischemic stroke (IS).
• To investigate the potential of targeting NK cells for therapeutic interventions in IS.
• To assess NK cells as biomarkers for IS diagnosis and prognosis.

Main Methods:

• Review of existing literature on NK cell function in the context of ischemic stroke.
• Analysis of NK cell involvement in inflammatory responses post-stroke.
• Examination of NK cell contributions to post-stroke immunosuppression and infection susceptibility.

Main Results:

• NK cells significantly influence post-stroke inflammation, potentially exacerbating ischemic brain injury.
• Dysregulation of NK cells is linked to immunosuppression, increasing the risk of infections after stroke.
• NK cells may serve as a link between IS and other related diseases.

Conclusions:

• Modulating NK cell activity presents a promising therapeutic avenue for mitigating ischemic damage and improving stroke outcomes.
• Targeting NK cells could offer novel treatment strategies for IS, addressing both the infarction and infectious complications.
• NK cells show potential as diagnostic or prognostic biomarkers for IS prevention and management.